Quarry LP’s Pfizer PFE Stock Holding History

Quarry LP’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-600,000	Closed	-$17.3M	–	1850
2023 Q4	$17.3M	Buy	600,000 +340,000	+131%	+$10.3M	2.67%	8
2023 Q3	$8.62M	Buy	+260,000	New	+$9.19M	2.01%	7

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quarry LP's PFE Position: Q2 2026 in Review

Quarry LP opened a new position in Pfizer (PFE) in Q2 2026: 227 shares worth $5.47K. The stake represents ﹤0.01% of the portfolio and ranks #1076 among its holdings. This is a return to the name: Quarry LP previously reported a position in PFE as recently as Q3 2024.

Quarry LP first reported a position in PFE in Q2 2024 and has held it in 3 quarters since. The position peaked at $476K in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Quarry LP held 227 shares of Pfizer worth $5.47K as of Q2 2026.
Pfizer was a new Quarry LP position in Q2 2026.
Pfizer made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1076 holding.
Quarry LP first reported a position in Pfizer in Q2 2024 and has held it in 3 quarters since.
Quarry LP's Pfizer position peaked at $476K in Q3 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.